Benalfocin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBenalfocin
Drug Alias Name1H-3-Benzazepine, 6-chloro-2,3,4,5-tetrahydro-3-methyl-,hydrochlorideSKF-86466
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsHypertensionProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHypertensionProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A